FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in the United Kingdom

Biotech startups that raised Series A in the United Kingdom

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in the United Kingdom
One-time CSV
  • 125 funded companies, 92 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~united-kingdom.csv125 rows × 18 columns
CompanyCityLast roundAmountDate
BiolibertyEdinburghSeries A$3.3M2026-11-02
Alchemab TherapeuticsLondonSeries A$33.6M2026-07-09
ApohaLondonSeries A$36.0M2026-06-03
Lucida MedicalCambridgeSeries A$11.5M2026-03-30
KluraLabsHaverhillSeries A$11.0M2026-02-03
EpilepsyGTxCanterburySeries A$33.0M2025-12-10
Verdiva BioLondonSeries A$411.0M2025-01-09
OxCanOxfordSeries A$11.0M2025-01-09

8 rows of the CSV in 5 of its 18 columns.

125
Startups
$2.6B
Total raised
19
Funded in the last 12 months
$712.1M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

14 of 125
14 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh Series A $3.3M 2026-11-02 $17.4M Innovate UK, Scottish Enterprise, Old College Capital +2 11 to 50 2020
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
Apoha Apoha is a start-up that has not yet publicly launched. Biotech London Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Cambridge Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
KluraLabs KluraLabs manufactures products that use nanotechnology to inactivate viruses and bacteria. Biotech Haverhill Series A $11.0M 2026-02-03 $11.0M Starship Ventures 11 to 50 2020
EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021
Verdiva Bio Verdiva Bio develops treatments for patients with obesity and cardiometabolic diseases. Biotech London Series A $411.0M 2025-01-09 $411.0M General Atlantic, RA Capital Management, OrbiMed +1 11 to 50 2024
OxCan OxCan develops machine learning and liquid biopsy tools for early lung cancer detection. Biotech Oxford Series A $11.0M 2025-01-09 $16.4M Civilization Ventures, Eka Ventures, Oxford Technology Management +1 11 to 50 2020
Solasta Bio Solasta Bio develops environmentally friendly crop protection products. Biotech Glasgow Series A $14.0M 2024-09-11 Scottish Enterprise, Future Planet Capital, Forbion Capital Partners 11 to 50 2020
Oxford Endovascular Oxford Endovascular develops a novel treatment for brain aneurysms. Biotech Oxford Series A $10.2M 2024-05-20 $28.4M Innovate UK, MedTech Innovator, Parkwalk Advisors +1 1 to 10 2015
Curve Therapeutics Curve Therapeutics develops a screening platform for drug discovery. Biotech Southampton Series A $51.4M 2024-02-27 Pfizer Venture Investments, British Patient Capital, Advent Life Sciences +2 11 to 50 2019
Mogrify Mogrify develops in vivo reprogramming therapies for patients with degenerative diseases. Biotech Cambridge Series A $10.0M 2023-10-02 Parkwalk Advisors, 24 Haymarket, Ahren Innovation Capital 11 to 50 2019
Sitryx Therapeutics Sitryx Therapeutics develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation. Biotech Oxford Series A $39.0M 2023-09-27 Sofinnova Partners, Oxford Science Enterprises, SV Health Investors +1 11 to 50 2018
YellowDog YellowDog provides cloud native scheduling and provisioning technology that helps businesses scale their computing workloads. Biotech Bristol Series A $3.3M 2019-03-27 $7.0M Bloc Ventures 11 to 50 2015

Table 1. Biotech startups that raised Series A in the United Kingdom: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 125.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Apoha Apoha is a start-up that has not yet publicly launched. Biotech London Series A $36.0M 2026-06-03 $36.0M Plug and Play, Innovate UK, Intel Ignite +2 1 to 10 2021
2 Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London Series A $33.6M 2026-07-09 $151.1M DCVC, RA Capital Management, DHVC +2 51 to 100 2019
3 EpilepsyGTx EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. Biotech Canterbury Series A $33.0M 2025-12-10 $43.0M UCL Technology Fund, HTH 1 to 10 2021
4 Lucida Medical Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. Biotech Cambridge Series A $11.5M 2026-03-30 $22.5M Innovate UK, XTX Ventures, WDH Investments 11 to 50 2019
5 KluraLabs KluraLabs manufactures products that use nanotechnology to inactivate viruses and bacteria. Biotech Haverhill Series A $11.0M 2026-02-03 $11.0M Starship Ventures 11 to 50 2020
6 Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh Series A $3.3M 2026-11-02 $17.4M Innovate UK, Scottish Enterprise, Old College Capital +2 11 to 50 2020

Table 2. Biotech startups that raised Series A in the United Kingdom: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Innovate UK Entrepreneurship program Swindon, United Kingdom 5 4% 3 Bioliberty, Apoha, Lucida Medical
2 Scottish Enterprise Government investment office Glasgow, United Kingdom 3 2% 1 Bioliberty
3 Parkwalk Advisors Venture capital firm London, United Kingdom 3 2%
4 SV Health Investors Private equity firm Boston, United States 2 2% 1 Alchemab Therapeutics
5 RA Capital Management Startup incubator Boston, United States 2 2% 1 Alchemab Therapeutics
6 Future Planet Capital Venture capital firm London, United Kingdom 2 2%
7 Octopus Ventures Venture capital firm London, United Kingdom 2 2%
8 Sofinnova Partners Venture capital firm Paris, France 2 2%
9 Oxford Science Enterprises Venture capital firm Oxford, United Kingdom 2 2%
10 IQ Capital Venture capital firm London, United Kingdom 2 2%
11 Archangels Angel group Edinburgh, United Kingdom 1 1% 1 Bioliberty
12 Eos Venture capital firm Saint Andrews, United Kingdom 1 1% 1 Bioliberty
13 Old College Capital University program Edinburgh, United Kingdom 1 1% 1 Bioliberty
14 DHVC Venture capital firm Palo Alto, United States 1 1% 1 Alchemab Therapeutics
15 DCVC Venture capital firm Palo Alto, United States 1 1% 1 Alchemab Therapeutics

Table 3. Biotech startups that raised Series A in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 91 73% $2.2B
Software 14 11% $223.4M
Hardware 8 6% $102.6M
Artificial intelligence 4 3% $157.9M
Fintech 3 2% $7.0M
Commerce 1 1% $11.0M
Energy 1 1%
Education 1 1%
Cybersecurity 1 1%

Table 4. Biotech startups that raised Series A in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 125 100% $12.2M

Table 5. Biotech startups that raised Series A in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 43 34%
Cambridge 19 15%
Oxford 11 9%
Edinburgh 6 5%
Manchester 4 3%
Glasgow 3 2%
Altrincham 2 2%
Coventry 2 2%
Bristol 2 2%
Abingdon 2 2%
Abingdon-on-thames 1 1%
Harrow 1 1%

Table 6. Biotech startups that raised Series A in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 11% $93.3M
October 2026 2 11% $35.0M
September 2026 2 11% $3.0M
July 2026 1 5% $33.6M
June 2026 4 21% $274.0M
May 2026 1 5% $82.6M
March 2026 3 16% $113.6M
February 2026 2 11% $19.1M
January 2026 1 5% $25.0M
December 2025 1 5% $33.0M

Table 7. Biotech startups that raised Series A in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 18 14% $679.1M
2025 12 10% $852.0M
2024 12 10% $434.3M
2023 16 13% $347.3M
2022 13 10% $267.4M
2021 9 7% $170.5M

Table 8. Biotech startups that raised Series A in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 6 5%
2020 to 2022 26 21%
2015 to 2019 50 40%
2010 to 2014 27 22%
Before 2010 15 12%

Table 9. Biotech startups that raised Series A in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 35 28%
11 to 50 78 63%
51 to 100 7 6%
101 to 250 2 2%
251 to 500 1 1%

Table 10. Biotech startups that raised Series A in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the United Kingdom whose last round is Series A are on the list?
125, in the file dated 16 November 2026. 19 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 125 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in the United Kingdom: 125 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in United Kingdom

Other sectors that raised Series A in United Kingdom

Cite: FundingWatcher, 125 biotech companies in the United Kingdom whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/united-kingdom/